Maja Mockenhaupt

15.3k total citations · 5 hit papers
119 papers, 9.5k citations indexed

About

Maja Mockenhaupt is a scholar working on Pharmacology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Maja Mockenhaupt has authored 119 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Pharmacology, 54 papers in Rheumatology and 53 papers in Pathology and Forensic Medicine. Recurrent topics in Maja Mockenhaupt's work include Drug-Induced Adverse Reactions (95 papers), Autoimmune Bullous Skin Diseases (53 papers) and Urticaria and Related Conditions (46 papers). Maja Mockenhaupt is often cited by papers focused on Drug-Induced Adverse Reactions (95 papers), Autoimmune Bullous Skin Diseases (53 papers) and Urticaria and Related Conditions (46 papers). Maja Mockenhaupt collaborates with scholars based in Germany, France and Italy. Maja Mockenhaupt's co-authors include Luigi Naldi, Jean‐Claude Roujeau, Peggy Sekula, Alexis Sidoroff, Ariane Dunant, Erwin Schöpf, Sima Halevy, Martin Schumacher, Berthold Rzany and Osvaldo Correia and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Journal of Immunology.

In The Last Decade

Maja Mockenhaupt

113 papers receiving 9.1k citations

Hit Papers

Medication Use and the Risk of Stevens–Johnson Syndrome o... 1995 2026 2005 2015 1995 2007 2013 2010 2008 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
    1995 1.0k citations Luigi Naldi, Berthold Rzany et al. profile →
  2. Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study
    2007 686 citations Maja Mockenhaupt, Cécile Viboud et al. Journal of Investigative Dermatology profile →
  3. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study
    2013 616 citations Peggy Sekula, Alexis Sidoroff et al. profile →
  4. ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis
    2010 474 citations Maja Mockenhaupt, Ariane Dunant et al. profile →
  5. A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
    2008 460 citations Peggy Sekula, Sima Halevy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maja Mockenhaupt Germany 44 7.8k 4.1k 3.6k 2.4k 1.1k 119 9.5k
Bénédicte Lebrun‐Vignes France 30 812 0.1× 614 0.2× 545 0.2× 309 0.1× 477 0.4× 120 3.9k
Ana Alfirevic United Kingdom 32 1.2k 0.2× 461 0.1× 415 0.1× 165 0.1× 452 0.4× 98 4.0k
Young‐Min Ye South Korea 30 691 0.1× 1.4k 0.3× 482 0.1× 653 0.3× 144 0.1× 208 3.5k
Melinda Gooderham Canada 46 226 0.0× 1.7k 0.4× 1.0k 0.3× 5.0k 2.1× 602 0.5× 350 8.6k
Yves Poulin Canada 44 154 0.0× 1.0k 0.2× 822 0.2× 4.7k 2.0× 942 0.9× 169 7.1k
Arthur L. Weaver United States 25 1.0k 0.1× 3.5k 0.9× 507 0.1× 74 0.0× 250 0.2× 38 5.6k
A. David Burden United Kingdom 41 225 0.0× 686 0.2× 697 0.2× 2.5k 1.0× 437 0.4× 96 4.8k
Gilles Hayem France 35 317 0.0× 1.6k 0.4× 310 0.1× 173 0.1× 464 0.4× 98 4.8k
H Isomäki Finland 31 600 0.1× 2.0k 0.5× 445 0.1× 131 0.1× 369 0.3× 109 3.7k
Jung‐Yoon Choe South Korea 36 336 0.0× 1.9k 0.5× 430 0.1× 75 0.0× 562 0.5× 218 4.4k

Countries citing papers authored by Maja Mockenhaupt

Since Specialization
Citations

This map shows the geographic impact of Maja Mockenhaupt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Mockenhaupt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Mockenhaupt more than expected).

Fields of papers citing papers by Maja Mockenhaupt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maja Mockenhaupt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Mockenhaupt. The network helps show where Maja Mockenhaupt may publish in the future.

Co-authorship network of co-authors of Maja Mockenhaupt

This figure shows the co-authorship network connecting the top 25 collaborators of Maja Mockenhaupt. A scholar is included among the top collaborators of Maja Mockenhaupt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maja Mockenhaupt. Maja Mockenhaupt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paulmann, Maren, et al.. (2023). Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis. Frontiers in Medicine. 10. 1125754–1125754. 1 indexed citations
2.
Bierbaum, Sibylle, Alexander Enk, Hartmut Hengel, et al.. (2023). Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020. Eurosurveillance. 28(50). 2 indexed citations
3.
Gibson, Andrew, Matthew S. Krantz, Eric Mukherjee, et al.. (2023). Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions. Journal of Allergy and Clinical Immunology. 151(2). 289–300.e4. 42 indexed citations
4.
Mockenhaupt, Maja, et al.. (2022). Bullous irritant contact dermatitis caused by the spitting palm, Euphorbia leuconeura BOISSIER. Contact Dermatitis. 87(5). 460–462. 1 indexed citations
5.
Hornuß, Daniel, Matthias Mueller, Susanne Usadel, et al.. (2022). Transmission characteristics, replication patterns and clinical manifestations of human monkeypox virus—an in-depth analysis of four cases from Germany. Clinical Microbiology and Infection. 29(1). 112.e5–112.e9. 17 indexed citations
6.
Sekula, Peggy, et al.. (2020). Incidence of Epidermal Necrolysis: Results of the German Registry. Journal of Investigative Dermatology. 140(12). 2525–2527. 10 indexed citations
7.
Pan, Ren‐You, Mu-Tzu Chu, Chuang‐Wei Wang, et al.. (2019). Identification of drug-specific public TCR driving severe cutaneous adverse reactions. Nature Communications. 10(1). 3569–3569. 88 indexed citations
8.
Brockow, Knut, Michael R. Ardern‐Jones, Maja Mockenhaupt, et al.. (2018). EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. Allergy. 74(1). 14–27. 131 indexed citations
9.
Paulmann, Maren & Maja Mockenhaupt. (2017). [Unintended rechallenge : Generalized bullous fixed drug eruption in two elderly women].. Der Hautarzt. 68(1). 59–63. 9 indexed citations
10.
Paulmann, Maren & Maja Mockenhaupt. (2015). Schwere arzneimittelinduzierte Hautreaktionen: Klinik, Diagnostik, Ätiologie und Therapie. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 13(7). 625–645. 12 indexed citations
11.
Struck, Manuel F., et al.. (2009). Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes. Intensive Care Medicine. 36(1). 22–32. 46 indexed citations
12.
Roujeau, Jean‐Claude, L. Allanore, Yvonne Liß, & Maja Mockenhaupt. (2009). Severe Cutaneous Adverse Reactions to Drugs (SCAR): Definitions, Diagnostic Criteria, Genetic Predisposition. 27(4). 203–209. 53 indexed citations
13.
Mockenhaupt, Maja, Cécile Viboud, Ariane Dunant, et al.. (2007). Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study. Journal of Investigative Dermatology. 128(1). 35–44. 686 indexed citations breakdown →
14.
Mockenhaupt, Maja. (2005). Severe cutaneous adverse drug reactions. Clinical features and epidemiology. Der Hautarzt. 56(1). 24–31. 4 indexed citations
15.
Mockenhaupt, Maja, Marco Idzko, Martine Grosber, Erwin Schöpf, & Johannes Norgauer. (2005). Epidemiology of Staphylococcal Scalded Skin Syndrome in Germany. Journal of Investigative Dermatology. 124(4). 700–703. 59 indexed citations
16.
Idzko, Marco, Elisabeth Panther, Stephan Sorichter, et al.. (2004). Lysophosphatidic Acid Induces Chemotaxis, Oxygen Radical Production, CD11b Up-Regulation, Ca2+ Mobilization, and Actin Reorganization in Human Eosinophils via Pertussis Toxin-Sensitive G Proteins. The Journal of Immunology. 172(7). 4480–4485. 54 indexed citations
17.
Panther, Elisabeth, Marco Idzko, Silvia Corinti, et al.. (2002). The Influence of Lysophosphatidic Acid on the Functions of Human Dendritic Cells. The Journal of Immunology. 169(8). 4129–4135. 83 indexed citations
18.
Weiss, Johannes M., Maja Mockenhaupt, Eric Schopf, & Jan C. Simon. (2001). Fixes Arzneimittelexanthem auf Terbinafin mit charakteristischem Verteilungsmuster eines Baboon-Syndroms. Der Hautarzt. 52(12). 1104–1106. 16 indexed citations
19.
Mockenhaupt, Maja & Erwin Schöpf. (1996). Epidemiology of drug-induced severe skin reactions. Seminars in Cutaneous Medicine and Surgery. 15(4). 236–243. 49 indexed citations
20.
Rzany, Berthold, et al.. (1994). Serious cutaneous adverse reactions differences in demography and past history of drug intake between Stevens-Johnson Syndrome /toxic epidermal necrolysis and generalized bullous fixed drug eruption. Journal of Investigative Dermatology. 102(4). 619. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bénédicte Lebrun‐Vignes Breakdown of academic impact, for papers by Ana Alfirevic Breakdown of academic impact, for papers by Young‐Min Ye Breakdown of academic impact, for papers by Melinda Gooderham Breakdown of academic impact, for papers by Yves Poulin Breakdown of academic impact, for papers by Arthur L. Weaver Breakdown of academic impact, for papers by A. David Burden Breakdown of academic impact, for papers by Gilles Hayem Breakdown of academic impact, for papers by H Isomäki Breakdown of academic impact, for papers by Jung‐Yoon Choe
Rankless by CCL
2026